1 Min Read
Sept 14 (Reuters) - Innovation Pharmaceuticals Inc
* Innovation Pharmaceuticals opens new clinical site for novel p53 drug candidate in Phase 2 ovarian cancer trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.